What does Becton Dickinson do?

BDX · Plain-English company overview

A stock is a share of ownership in a company. Owning one means you own a small piece of that business.

In the company's own words, from Item 1 (Business) of its latest annual report (Form 10-K) filed with the SEC on 2025-11-25.

Becton, Dickinson and Company (also referred to herein as "BD") was incorporated under the laws of the State of New Jersey in November 1906, as successor to a New York business started in 1897. BD’s executive offices are located at 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880, and its telephone number is (201) 847-6800. All references in this Form 10-K to "BD", "the Company", "we", "our" or "us" refer to Becton, Dickinson and Company and its domestic and foreign subsidiaries, unless otherwise indicated by the context.

BD is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. We provide customer solutions that are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology care; enhancing the diagnosis of infectious diseases and cancers; and advancing cellular research and applications.

Read the full 10-K on SEC.gov →

How did Becton Dickinson's latest earnings compare?

An earnings release is a company's quarterly report of how much money it made. Analysts predict these numbers ahead of time, and the actual results are compared against those predictions.

In the most recent quarter (2026-06-30), Becton Dickinson reported earnings of $3.23 per share. Analysts expected $3.1728 per share, so the company beat expectations.

SEC Filings

Key filings
Annual report (10-K)
The company's big yearly financial report.
2025-11-25
Quarterly report (10-Q)
A financial update covering the last 3 months.
2026-08-06
Material event (8-K)
A heads-up about something important that just happened.
2026-08-06
Most recent filings
Proposed share sale (144)
Notice that an insider plans to sell some shares.
2026-08-26
Insider trade (4)
An executive or director bought or sold company shares.
2026-08-24
Proposed share sale (144)
Notice that an insider plans to sell some shares.
2026-08-20
Insider trade (4)
An executive or director bought or sold company shares.
2026-08-14
Proposed share sale (144)
Notice that an insider plans to sell some shares.
2026-08-13
Insider trade (4)
An executive or director bought or sold company shares.
2026-08-12
Proposed share sale (144)
Notice that an insider plans to sell some shares.
2026-08-11
SEC filing (SCHEDULE 13G)
An official filing with the SEC.
2026-08-07
Insider trade (4)
An executive or director bought or sold company shares.
2026-08-06
Insider trade (4)
An executive or director bought or sold company shares.
2026-08-06
View all filings on SEC.gov →

Browse all companies A–Z →

Look up any company on Zelothorn →

Zelothorn provides plain-English summaries drawn from official SEC filings for educational purposes only. It is not financial advice and does not recommend buying or selling any security.